Showing results (441-450 of 764) with videos related to

Sort By:
Pageof 77
Clinical Prostate Cancer|May 11, 2005
Lifestyle correlates of health perception and treatment satisfaction in a clinical cohort of men with prostate cancerSara K Sheriff, Ryo A Shohara, Sarah B Dumican, et al.
The Journal of Urology|October 22, 2008
Pretreatment predictors of death from other causes in men with prostate cancerNicole L Simone, Anurag K Singh, Janet E Cowan, et al.
Science Signaling|November 19, 2015
Cell type-specific abundance of 4EBP1 primes prostate cancer sensitivity or resistance to PI3K pathway inhibitorsAndrew C Hsieh, Hao G Nguyen, Lexiaochuan Wen, et al.
Urology|March 26, 2013
Benign prostate glandular tissue at radical prostatectomy surgical marginsAnobel Y Odisho, Samuel L Washington, Maxwell V Meng, et al.
European Urology|January 20, 2009
The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancerAlexander Karl, Peter R Carroll, Jürgen E Gschwend, et al.
The Journal of Urology|November 25, 2003
Predictors of treatment after initial surveillance in men with prostate cancer: results from CaPSUREMaxwell V Meng, Eric P Elkin, Susan R Harlan, et al.
The Journal of Urology|March 26, 2002
How well does the Partin nomogram predict pathological stage after radical prostatectomy in a community based population? Results of the cancer of the prostate strategic urological research endeavorDavid F Penson, Gary D Grossfeld, Yu-Ping Li, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Does local recurrence of prostate cancer after radiation therapy occur at the site of primary tumor? Results of a longitudinal MRI and MRSI studyElnasif Arrayeh, Antonio C Westphalen, John Kurhanewicz, et al.
The Journal of Urology|December 13, 2006
Quality of life for men receiving a second treatment for prostate cancerShelley A Arredondo, David M Latini, Natalia Sadetsky, et al.
Cancer|October 14, 2006
Cancer-specific mortality after radiation therapy with short-course hormonal therapy or radical prostatectomy in men with localized, intermediate-risk to high-risk prostate cancerHenry K Tsai, Ming-Hui Chen, David G McLeod, et al.
Pageof 77